Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free RPRX Stock Alerts

Royalty Pharma (RPRX) Short Interest Ratio & Short Volume

Royalty Pharma logo
$58.66 +0.11 (+0.18%)
As of 10:23 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Royalty Pharma Short Interest Overview

As of July 31, 2026, Royalty Pharma (RPRX) had a short interest of 10.67 million shares sold short, representing 2.28% of the public float. This marks a -12.09% decrease in short interest since the prior report. The short interest ratio (days to cover) is 4.1, meaning it would take 4.1 days of the average trading volume of 3.53 million shares to cover all short positions.

Current Short Interest
10,667,818 shares
Previous Short Interest
12,134,646 shares
Change Vs. Previous Month
-12.09%
Dollar Volume Sold Short
$623.32 million
Short Interest Ratio
4.1 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
575,830,000 shares
Short Percent of Float
2.28%
Today's Trading Volume
126,705 shares
Average Trading Volume
3,530,678 shares
Today's Volume Vs. Average
4%
Short Selling Royalty Pharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Royalty Pharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

RPRX Short Interest Over Time

RPRX Days to Cover Over Time

RPRX Percentage of Float Shorted Over Time

Royalty Pharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202610,667,818 shares $623.32 million -12.1%2.3%4.07 $58.43
7/15/202612,134,646 shares $683.30 million -2.5%2.6%4.44 $56.31
6/30/202612,443,449 shares $697.70 million +11.8%2.7%2.98 $56.07
6/15/202611,133,208 shares $604.20 million -3.9%2.4%3.04 $54.27
5/29/202611,588,307 shares $646.16 million -8.6%2.5%2.47 $55.76
5/15/202612,683,834 shares $670.34 million -8.2%2.7%3.32 $52.85
4/30/202613,816,927 shares $692.09 million +15.0%3.0%4.41 $50.09
4/15/202612,011,065 shares $584.94 million +4.3%2.6%4.36 $48.70
3/31/202611,520,329 shares $552.63 million -0.5%2.5%3.31 $47.97
3/13/202611,579,085 shares $528.59 million -4.8%2.5%3.44 $45.65
2/27/202612,161,157 shares $561.97 million -9.5%2.6%4.27 $46.21
2/13/202613,443,797 shares $607.53 million -49.2%2.9%3.03 $45.19
1/30/202626,462,455 shares $1.10 billion -3.8%5.7%7.2 $41.68
1/15/202627,513,663 shares $1.09 billion -4.5%5.9%6.96 $39.72
12/31/202528,800,189 shares $1.11 billion +3.9%6.2%9.29 $38.64
12/15/202527,721,192 shares $1.07 billion +13.9%5.9%5.45 $38.53
11/28/202524,331,177 shares $977.51 million +1.3%5.2%6.48 $40.18
11/14/202524,029,541 shares $941.00 million +69.3%5.1%4.49 $39.16
10/31/202514,193,421 shares $532.82 million +4.6%3.0%6.15 $37.54
10/15/202513,580,000 shares $491.32 million +5.5%4.0%3.6 $36.18
9/30/202512,870,000 shares $454.05 million -39.5%3.8%3.4 $35.28
9/15/202521,280,000 shares $747.99 million +28.0%6.3%5.3 $35.15
8/31/202516,620,000 shares $597.99 million +18.1%4.9%4.5 $35.98
8/15/202514,070,000 shares $511.44 million -7.3%4.1%3.8 $36.35
7/31/202515,180,000 shares $558.62 million -9.3%4.6%3.5 $36.80
7/15/202516,730,000 shares $610.81 million -1.1%5.0%3.7 $36.51
6/30/202516,910,000 shares $609.27 million -41.8%5.1%3.5 $36.03
6/15/202529,030,000 shares $1.01 billion +0.0%8.7%5.6 $34.84
5/31/202529,020,000 shares $959.40 million +39.9%8.7%5.9 $33.06
5/15/202520,740,000 shares $686.91 million +11.6%6.2%4.3 $33.12
4/30/202518,590,000 shares $610.12 million -9.6%5.4%4 $32.82
4/15/202520,570,000 shares $667.50 million +14.2%6.2%4.5 $32.45
3/31/202518,010,000 shares $560.65 million +15.7%5.4%3.8 $31.13
3/15/202515,570,000 shares $510.23 million +13.2%4.7%3.7 $32.77
2/28/202513,750,000 shares $462.55 million -10.1%4.1%3.3 $33.64
2/15/202515,300,000 shares $495.11 million -5.2%4.1%3.9 $32.36
1/31/202516,130,000 shares $509.39 million -3.0%4.2%4.3 $31.58
1/15/202516,630,000 shares $511.21 million +0.4%4.4%5 $30.74
12/31/202416,560,000 shares $422.45 million +5.8%4.4%5.8 $25.51
12/15/202415,650,000 shares $388.75 million -0.3%4.1%5.8 $24.84
The world’s most valuable stock-picking messages? (Ad)

Tomorrow morning, a small group of investors will receive a text alert tied to what may be the most powerful stock rating software in the world - and every message it has sent has averaged a gain of 310 percent, including the misses. Members of this exclusive list have seen nearly 3,000 chances to double their money and over 400 chances to 10x it. The next alert goes out as early as 9:30 a.m.tc pixel

Learn how to sign up and receive the next alert today
11/30/202415,700,000 shares $418.56 million +7.0%4.1%6.4 $26.66
11/15/202414,670,000 shares $377.02 million +0.8%3.9%6.1 $25.70
10/31/202414,550,000 shares $392.85 million +0.6%3.8%6.5 $27.00
10/15/202414,460,000 shares $402.57 million -0.8%3.8%6 $27.84
9/30/202414,570,000 shares $412.19 million +2.7%3.8%5.9 $28.29
9/15/202414,190,000 shares $393.35 million -3.3%3.7%5.4 $27.72
8/31/202414,680,000 shares $426.16 million +2.8%3.8%5.5 $29.03
8/15/202414,280,000 shares $391.41 million -4.0%3.7%5 $27.41
7/31/202414,870,000 shares $418.89 million -9.8%3.9%5.4 $28.17
7/15/202416,490,000 shares $439.46 million -2.4%4.3%6.1 $26.65
6/30/202416,900,000 shares $445.65 million +8.8%4.4%6.1 $26.37
6/15/202415,540,000 shares $418.34 million +17.3%4.1%5.8 $26.92
5/31/202413,250,000 shares $363.18 million -0.2%3.5%4.9 $27.41
5/15/202413,280,000 shares $374.63 million -3.4%3.5%5.1 $28.21
4/30/202413,750,000 shares $380.88 million -2.8%3.6%4.8 $27.70
4/15/202414,150,000 shares $399.74 million +14.2%3.7%5.2 $28.25
3/31/202412,390,000 shares $376.28 million -2.1%3.3%4.7 $30.37
3/15/202412,650,000 shares $380.64 million -3.7%3.3%4.9 $30.09
2/29/202413,130,000 shares $398.36 million +14.2%3.5%4.8 $30.34
2/15/202411,500,000 shares $345.35 million +11.9%3.0%4.1 $30.03
1/31/202410,280,000 shares $291.85 million +0.9%2.7%4.1 $28.39
1/15/202410,190,000 shares $289.19 million -9.1%2.7%4.3 $28.38
12/31/202311,210,000 shares $314.89 million -9.2%2.9%4.8 $28.09
12/15/202312,340,000 shares $337.75 million +23.3%3.2%5.3 $27.37
11/30/202310,010,000 shares $270.97 million +1.8%2.6%4.3 $27.07
11/15/20239,830,000 shares $265.61 million -10.4%2.6%4.5 $27.02
10/31/202310,970,000 shares $294.76 million -2.8%2.9%5 $26.87
10/15/202311,290,000 shares $314.31 million +8.0%3.0%5.2 $27.84
9/30/202310,450,000 shares $283.61 million +11.7%2.8%4.8 $27.14
9/15/20239,360,000 shares $263.30 million +9.5%2.5%4.3 $28.13
8/31/20238,550,000 shares $254.96 million -8.7%2.3%3.7 $29.82
8/15/20239,360,000 shares $278.93 million +0.2%2.5%3.9 $29.80
7/31/20239,340,000 shares $293.09 million -14.2%2.5%3.9 $31.38
7/15/202310,890,000 shares $334.65 million +23.2%2.9%4.6 $30.73
6/30/20238,840,000 shares $271.74 million +1.1%2.4%3.9 $30.74
6/15/20238,740,000 shares $281.43 million +15.3%2.3%4 $32.20
5/31/20237,580,000 shares $248.17 million +5.6%2.0%3.7 $32.74
5/15/20237,180,000 shares $246.49 million -7.4%1.9%3.7 $34.33
4/30/20237,750,000 shares $272.41 million +1.7%2.1%4.1 $35.15
4/15/20237,620,000 shares $276.30 million +0.9%2.1%4.1 $36.26
3/31/20237,550,000 shares $272.03 million -1.2%2.0%4 $36.03
3/15/20237,640,000 shares $263.58 million +3.7%2.1%4.2 $34.50
2/28/20237,370,000 shares $264.21 million +7.1%2.0%4.5 $35.85
2/15/20236,880,000 shares $259.31 million +8.2%1.9%4.4 $37.69
1/31/20236,360,000 shares $249.25 million -10.4%1.7%4.2 $39.19
1/15/20237,100,000 shares $279.53 million -9.0%1.9%4.8 $39.37
12/30/20227,800,000 shares $308.26 million +4.4%2.1%5.3 $39.52
12/15/20227,470,000 shares $304.70 million -2.9%2.0%4.9 $40.79
11/30/20227,690,000 shares $338.13 million +35.6%2.1%4.7 $43.97
11/15/20225,670,000 shares $238.59 million -14.7%1.6%3.4 $42.08
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
10/31/20226,650,000 shares $281.43 million -22.1%1.8%4.1 $42.32
10/15/20228,540,000 shares $353.64 million -0.5%2.4%5 $41.41
9/30/20228,580,000 shares $344.74 million -5.3%2.4%4.6 $40.18
9/15/20229,060,000 shares $382.06 million -9.9%2.5%4.6 $42.17
8/31/202210,050,000 shares $420.19 million -17.3%2.8%5.2 $41.81
8/15/202212,150,000 shares $533.75 million -10.0%3.3%6.2 $43.93
7/31/202213,500,000 shares $587.12 million +0.5%3.7%6.4 $43.49
7/15/202213,430,000 shares $589.98 million +0.8%3.7%6.2 $43.93
6/30/202213,330,000 shares $560.39 million -2.9%3.7%5.7 $42.04
6/15/202213,730,000 shares $529.02 million +35.9%3.8%5.7 $38.53
5/31/202210,100,000 shares $415.51 million +21.0%2.8%4.7 $41.14
5/15/20228,350,000 shares $333.50 million +13.5%2.3%4 $39.94
4/30/20227,360,000 shares $313.39 million -10.1%2.0%3.8 $42.58
4/15/20228,190,000 shares $361.18 million +17.5%2.3%4.4 $44.10
3/31/20226,970,000 shares $271.55 million +11.3%1.9%4.1 $38.96
3/15/20226,260,000 shares $239.57 million +4.5%1.7%4.1 $38.27
2/28/20225,990,000 shares $235.17 million +7.2%1.7%3.7 $39.26
2/15/20225,590,000 shares $225.50 million -7.3%1.6%3 $40.34
1/31/20226,030,000 shares $241.26 million -4.3%1.7%2.9 $40.01
1/15/20226,300,000 shares $249.86 million +7.7%1.8%2.9 $39.66
12/31/20215,850,000 shares $233.12 million -17.7%1.6%2.8 $39.85
12/15/20217,110,000 shares $266.77 million +20.3%2.0%3.5 $37.52
11/30/20215,910,000 shares $235.04 million -10.1%1.7%2.4 $39.77
11/15/20216,570,000 shares $273.97 million -17.6%1.9%2.8 $41.70
10/29/20217,970,000 shares $315.05 million +2.1%2.4%3.7 $39.53
10/15/20217,810,000 shares $299.83 million -7.4%2.3%3.3 $38.39
9/30/20218,430,000 shares $304.66 million +40.3%2.5%3.5 $36.14
9/15/20216,010,000 shares $228.20 million +2.2%1.8%2.4 $37.97
8/31/20215,880,000 shares $227.26 million -22.5%1.8%2.7 $38.65

RPRX Short Interest - Frequently Asked Questions

Short interest is the volume of Royalty Pharma shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 10,667,818 shares of RPRX short. 2.28% of Royalty Pharma's shares are currently sold short. Learn More on Royalty Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPRX shares currently have a short interest ratio of 4.1. Learn More on Royalty Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.28% of Royalty Pharma's floating shares are currently sold short.

Royalty Pharma saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 10,667,818 shares, a drop of 12.1% from the previous total of 12,134,646 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.28% of Royalty Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Royalty Pharma: GSK PLC Sponsored ADR (0.80%), Sanofi (0.42%), Takeda Pharmaceutical Co. (0.09%), Teva Pharmaceutical Industries Ltd. (2.96%), BeOne Medicines Ltd. - Sponsored ADR (0.86%), Zoetis Inc. (5.10%), Viatris Inc. (3.93%), Jazz Pharmaceuticals PLC (5.39%), Neurocrine Biosciences, Inc. (4.53%), Corcept Therapeutics Incorporated (11.46%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling RPRX is an investing strategy that aims to generate trading profit from Royalty Pharma as its price is falling. RPRX shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Royalty Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RPRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPRX, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like RPRX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:RPRX is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
How the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement Accounts
JPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...
Golden Crest Metals | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...
Decentralized Masters | Sponsoredtc pixel
American retirees will miss THIS. Big Banks just moved in.
Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...
Cedar Gold Group | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel